Bausch & Lomb Beats Sandoz Challenge To Eye Drops Patent
Bausch & Lomb has defeated a generic drugmaker's challenge to an amended patent for its blockbuster eye drops, after European officials found that its use of a particular inactive ingredient wasn't...To view the full article, register now.
Already a subscriber? Click here to view full article